BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

RAYNER — Lobbying — Receipts Report

LD-2 disclosure · 3rd Quarter - Report

RAYNER

via WILLIAMS AND JENSEN, PLLC

3rd Quarter (July 1 - Sep 30) · 2025Posted Oct 20, 2025Filing document ↗LDA record ↗

Income$60Kfee reported

Client

Name: RAYNER
Description: Manufacturer of ophthalmic medical products.
Location: United Kingdom

Registrant

Firm: WILLIAMS AND JENSEN, PLLC
Description: Lobbying Law Firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Medicare/Medicaid
Medicare coverage issue for non-opioid product. Reauthorization of NOPAIN Act.
LobbyistsSUSAN HIRSCHMANN · LAURA M SIMMONS · JEANNE HAGGERTY · KURT SCHRADER
Covered position (LAURA M SIMMONS): Advisor, Office of Legislative Affairs, Dept of Homeland Security
Covered position (JEANNE HAGGERTY): Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member
Covered position (KURT SCHRADER): Former Member of Congress
TargetedSENATE · HOUSE OF REPRESENTATIVES · Centers For Medicare and Medicaid Services (CMS)

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.